Evidence map›Paper›PMID 34159287›Full record

ArticleJournal of the Endocrine Society2021

Parafibromin Abnormalities in Ossifying Fibroma.

Jessica Costa-Guda, Chetanya Pandya, Maya Strahl, Patricia Taik, Robert Sebra, Rong Chen, Andrew V Uzilov, Andrew Arnold

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the Endocrine Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Phenotypic Profiling and Molecular Mechanisms in Hyperparathyroidism-jaw Tumor Syndrome.The Journal of clinical endocrinology and metabolism · 2023
    Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jessica Costa-GudaCenter for Molecular Oncology, University of Connecticut School of Medicine, Farmington, CT 06030, USA.ORCID https://orcid.org/0000-0001-6437-1693
Chetanya PandyaSema4, a Mount Sinai venture , Stamford, CT 06902, USA.ORCID https://orcid.org/0000-0003-2683-6925
Maya StrahlSema4, a Mount Sinai venture , Stamford, CT 06902, USA.ORCID https://orcid.org/0000-0001-6244-1766
Patricia TaikSema4, a Mount Sinai venture , Stamford, CT 06902, USA.ORCID https://orcid.org/0000-0003-0990-7832
Robert SebraSema4, a Mount Sinai venture , Stamford, CT 06902, USA.
Rong ChenSema4, a Mount Sinai venture , Stamford, CT 06902, USA.
Andrew V UzilovSema4, a Mount Sinai venture , Stamford, CT 06902, USA.
Andrew ArnoldCenter for Molecular Oncology, University of Connecticut School of Medicine, Farmington, CT 06030, USA.
Sema4 (United States) · USUniversity of Connecticut · US

Funding

Modeling of Hyperparathyroidism-Jaw Tumor Syndrome by Targeted Deletion of Hrpt2F32DE021307 · NIDCR · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI COSTA, JESSICA · 2010 to 2012
$110k
NIDCR NIH HHS F32 DE021307
6 · The paper itself

Abstract

Ossifying fibromas are very rare tumors that are sometimes seen as part of the hyperparathyroidism-jaw tumor syndrome (HPT-JT), which is caused by inactivating mutations of the

Indexed as

CDC73hyperparathyroidism-jaw tumor syndromejaw neoplasmsossifying fibromaparafibromin

Identifiers

PMID34159287
PMCPMC8212678
OpenAlexW3161815375

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.